Isolated growth hormone deficiency type II (IGHD2) is mainly caused by 27 heterozygous splice-site mutations in intron 3 of the GH1 gene. A dominant negative 28 effect of the mutant growth hormone (GH) lacking exon 3 on wild-type GH secretion has 29 been proposed; however, the molecular mechanisms involved are elusive. To uncover 30 the molecular systems underlying GH deficiency in IGHD2, we established IGHD2 31 model mice, which carry both wild-type and mutant copies of the human GH1 gene, 32
Introduction 46 47 Isolated growth hormone deficiency type II (IGHD2) is a dominantly inherited 48 growth hormone (GH) deficiency, first described in 1994, and mainly caused by 49 heterozygous splice-site mutations in intron 3 of the GH1 gene (Binder & Ranke, 1995; 50 Cogan et al, 1994) . The wild-type GH1 allele transcript includes 5 exons and produces a 51
IGHD2 model mice exhibited mild growth retardation 114
To establish a mouse model that authentically demonstrates the Δ3 GH-mediated 115 dominant negative effect observed in IGHD2, one each of the mouse endogenous Gh 116 gene alleles was exchanged for the human wtGH1 and Δ3GH1 genes, using the gene 117 exchange system previously reported by our laboratory (Araki et al, 2002) . Briefly, we 118 inserted a neoR gene cassette, flanked by a left-element mutated loxJT15 and loxP site, 119 at the Gh gene locus by homologous recombination, producing a mouse Gh knock-out 120 (KO) allele (Gh -) ( Fig EV1A and C) . Then, we constructed gene exchange vectors, 121 containing right-element mutated loxKR3 and the wtGH1 or Δ3GH1 genes, followed by 122 a puromycin resistance gene and the loxP site ( Fig EV1A and C) . The neoR gene 123 cassette was exchanged for the wtGH1 or Δ3GH1 genes using Cre-mediated 124 recombination ( Fig EV1A and B) . Since recombination between loxJT15 and loxKR3 125 produced a lox site with both sides mutated, which is resistant to Cre-mediated excision, 126
we were able to efficiently generate recombined embryonic stem (ES) cell clones ( with serum insulin-like growth factor 1 (IGF-1) levels below the detection range, 136
indicating that, as in humans, postnatal growth in mice is dependent on GH activity . Gh wtGH1/wtGH1 and Gh wtGH1/mice showed longitudinal growth and serum IGF-1 138 levels comparable with those of Gh +/+ mice, suggesting that the human wild-type GH 139 molecule is capable of binding the mouse GH receptor and producing IGF-1, and that 140 one exchanged human wild-type GH1 allele is sufficient for IGF-1-mediated longitudinal 141 growth in mice ( Fig 1B-E) . Gh wtGH1/Δ3GH1 mice exhibited mild growth retardation, 142 associated with significantly reduced serum IGF-1 values, which were intermediate 143 between those of Gh wtGH1/wtGH1 and Gh -/mice ( Fig 1B-E) . These data indicate that 144
Gh wtGH1/Δ3GH1 mice successfully demonstrate the dominant negative effect of Δ3 GH, and 145 that the growth retardation of Gh wtGH1/Δ3GH1 mice is caused by impaired GH activity. 146
We also established Gh mGh/Δ3GH1 mice, in which the mouse Gh gene was inserted 147 at the endogenous mouse Gh locus, using the gene exchange system in a similar way 148 to that used to obtain Gh wtGH1/Δ3GH1 mice ( Fig EV1A) . Gh mGh/Δ3GH1 mice also 149 demonstrated growth failure, as for Gh wtGH1/Δ3GH1 mice, although Gh +/Δ3GH1 mice did not 150 ( Fig EV1E) . The phenotypic discrepancy between Gh +/Δ3GH1 and Gh mGh/Δ3GH1 mice was 151 attributable to a significant difference in the abundance of mRNA transcribed from the 152 endogenous and exchanged Gh alleles, as demonstrated by qRT-PCR ( Fig EV1F) . In 153 this study, we used mouse lines in which both alleles were exchanged for human GH1 154 genes, because the transcriptional efficiencies of the wtGH1 and Δ3GH1 alleles were 155 basically equivalent in human IGHD2 patients. These decreases in transcriptional 156 efficiency of the exchanged human GH1 genes did not cause the growth failure in 157 Gh wtGH1/wtGH1 mice ( Fig 1B and C) , and IGF-1 levels in Gh wtGH1/wtGH1 mice were 158 comparable with those in Gh +/+ mice (Fig 1D) , indicating that wtGH1 mRNA expression 159 levels were sufficient for production of human wild-type GH protein, required for the 160 IGF-1-mediated longitudinal growth of mice. 161
162
The growth retardation of Gh wtGH1/Δ3GH1 mice is caused by decreased wtGH1 mRNA 163 expression 164
We evaluated the expression levels of wild-type and Δ3 GH proteins in pituitary 165 glands at 4 weeks of age, the period in which Gh wtGH1/Δ3GH1 mice demonstrated 166 significant growth retardation, based on their growth curves ( Fig 1B and C) . 167
Immunoblotting showed significant decreases in the content of the 22 kDa wild-type GH 168 6 in whole Gh wtGH1/Δ3GH1 pituitary, compared with Gh wtGH1/wtGH1 and Gh wtGH1/pituitaries ( Fig  169   2A left and B) , indicating that the growth retardation of Gh wtGH1/Δ3GH1 mice was caused by 170 impaired GH production in the somatotroph. Δ3 GH expression was barely detected by 171 long exposure (Fig 2A right) , despite comparable affinities of the anti-GH antibody for 172 wild-type and Δ3 GH proteins ( Fig EV2A) . Immunostaining revealed that both the 173 wild-type GH content in each somatotroph and the number of somatotrophs were 174 reduced in Gh wtGH1/Δ3GH1 , compared with Gh wtGH1/wtGH1 pituitaries ( Fig 2C) . 175
Since we had demonstrated impaired production of wild-type GH in Gh wtGH1/Δ3GH1 176 pituitary, we next evaluated GH1 transcript levels. Using whole pituitary glands from 177 4-week-old animals, RT-PCR detecting both the wtGH1 and Δ3GH1 transcripts, with a 178 sense primer in exon 1 and an antisense primer in exon 5, revealed markedly 179 decreased wtGH1 transcript levels in the Gh wtGH1/Δ3GH1 pituitary, compared with those in 180 Gh wtGH1/wtGH1 and Gh wtGH1/pituitaries ( Fig 2D) . qRT-PCR analysis, detecting the wtGH1 181 mRNA alone, using a sense primer in exon 3 and an antisense primer spanning exons 3 182 and 4, also demonstrated that the abundance of the wtGH1 mRNA in Gh wtGH1/Δ3GH1 183 pituitary was approximately one sixth of that in Gh wtGH1/wtGH1 pituitary in 4-week-old 184 animals ( Fig 2E) . Decreases in wtGH1 mRNA levels in Gh wtGH1/Δ3GH1 pituitaries were 185 demonstrated from embryonic day E19.5 to 4 weeks of age ( Fig 2F) , suggesting that 186 GH production in Gh wtGH1/Δ3GH1 pituitaries was already impaired before birth. In situ 187 hybridization analysis to detect wtGH1 mRNA using an RNA probe for GH1 exon 3, in 188 E19.5 and 4-week-old pituitaries, revealed that both the abundance of wtGH1 mRNA in 189 each somatotroph and the number of somatotrophs were decreased in Gh wtGH1/Δ3GH1 190 pituitaries, consistent with the results of immunostaining ( Fig 2C and G) . These data 191 indicate that the impaired production of wild-type GH in Gh wtGH1/Δ3GH1 pituitary is caused 192 by a decrease in wtGH1 mRNA. 193
RT-PCR showed that levels of the wtGH1 and Δ3GH1 transcripts were 194 comparable ( Fig 2D) ; however, immunoblotting revealed that expression of the Δ3 GH 195 protein was drastically reduced compared with that of wild-type GH protein in 196 Gh wtGH1/Δ3GH1 pituitaries (Fig 2A) . These data indicate that Δ3 GH is degraded in the 197 somatotroph, and that wild-type GH is not involved in the degradation, inconsistent with 198 the currently accepted hypothesis. Thus, to evaluate whether wild-type GH 199 preferentially interacts with Δ3 GH, 3-D protein structures of wild-type and Δ3 GH were 200 analyzed under pH conditions in the ER and docking simulation analysis was conducted 201 using ZDOCK (Chen et al, 2003; Nakamura et al, 2017) . The average binding affinity 202 score for heterodimers of wild-type and Δ3 GH was significantly lower than that for the 203 wild-type GH homodimer (Table 1) , indicating that wild-type and Δ3 GH heterodimer 7 formation is unlikely to be involved in impaired GH secretion in IGHD2. 205 206 Electron microscopy reveals markedly decreased numbers of secretory vesicles 207 and enlarged ER in Gh wtGH1/Δ3GH1 pituitaries 208
Considering the possibility that somatotroph loss due to apoptosis, necrosis, and 209 inflammation, contribute to the decrease in wtGH1 mRNA described above, we 210 conducted histological evaluation of pituitary glands (Fig 3) . Stereomicroscopic analysis 211 of four-week-old Gh wtGH1/Δ3GH1 pituitaries revealed a slightly atrophic and 212 semi-translucent appearance, which was intermediate between those of Gh wtGH1/and 213
Gh -/mice, consistent with the decreased somatotroph number in Gh wtGH1/Δ3GH1 mice 214 described above ( Fig 3A) ; however, the decrease in somatotroph number was not 215 caused by somatotroph loss, since hematoxylin-eosin staining demonstrated that the 216 cellular architecture was intact, with no signs of necrosis or inflammation. Further, 217 analysis by TdT-mediated dUTP nick end labeling (TUNEL) assay revealed that the 218 decrease in the wtGH1 mRNA in Gh wtGH1/Δ3GH1 mice was not associated with apoptosis 219 ( Fig 3B) . 220
The absence of somatotroph loss in Gh wtGH1/Δ3GH1 mice led us to evaluate the 221 characteristics of the cellular organelles in pituitary glands using transmission electron 222 microscopy (TEM). TEM images of 4-week-old Gh wtGH1/wtGH1 pituitary glands showed 223 intact cell organelles, including appropriately developed rough ER, and many secretory 224 vesicles containing mature wild-type GH protein ( Fig 3C) . In contrast, images of 225 Gh wtGH1/Δ3GH1 pituitary glands revealed a clear decrease in the number of secretory 226 vesicles, abnormal enlargement of the rough ER, and protein aggregates in the cytosol 227 ( Fig 3C) . To evaluate the impact of Δ3 GH itself on cellular morphology, we obtained 228 Gh Δ3GH1/mice by crossing Gh wtGH1/and Gh wtGH1/Δ3GH1 animals. In contrast to the current 229 understanding that Δ3 GH itself is not harmful to somatotroph, TEM images of Gh Δ3GH1/-230 pituitaries revealed extreme enlargement of the rough ER and protein aggregates in the 231 cytosol, whereas such abnormalities were not visible in Gh -/pituitaries ( Fig 3D) . The 232 observed protein aggregates were connected to the ER (Fig 3E) , suggesting that the 233 proteins accumulated in the ER were retro-translocated to the cytosol, leading to 234 aggregate formation. These data led us to confirm the cellular localization of Δ3 GH by 235 immunofluorescence analysis. Using Gh wtGH1/Δ3GH1-myc mice, expressing Δ3 GH with a 236 C-terminal myc tag ( Fig EV1A) , Δ3 GH was also demonstrated to localize within the ER 237 in vivo ( Fig 3F) . 238
To evaluate the contents of the protein aggregates in the cytosol, we dissociated 239 Gh wtGH1/Δ3GH1 anterior pituitary cells and separated them into soluble and insoluble 240 8 fractions, in the presence or absence of treatment with the proteasome inhibitor, MG132, 241 and evaluated the distributions of wild-type and Δ3 GH by immunoblotting, because 242 several studies have demonstrated that cytosolic protein aggregates have low solubility 243 (Ariyasu et al, 2013; Imai et al, 2001; Kannenberg et al, 2007; Ward et al, 1995) . A 244 significant proportion of Δ3 GH was detected in the insoluble fraction following MG132 245 treatment, although the majority of wild-type GH was sorted into the soluble fraction ( Fig  246   EV2B ). These data suggest that ER-localized Δ3 GH is degraded by the proteasome, 247 leading to Δ3 GH aggregation, which overwhelms the degradative capacity in the 248 cytosol, and that most wild-type GH is not involved in the aggregates. 249 250 Δ3 GH-mediated ER stress is not a direct cause of the growth failure of 251
Gh wtGH1/Δ3GH1 mice 252
The enlargement of the rough ER and Δ3 GH aggregates in the cytosol suggest 253 that the Gh wtGH1/Δ3GH1 somatotrophs are under ER stress, and we have previously shown 254 that Δ3 GH causes ER stress to the somatotroph in vitro (Ariyasu et al, 2013) . These 255 data led us to investigate Δ3 GH-mediated ER stress in vivo. PKR-like endoplasmic 256 reticulum kinase (PERK), activating transcription factor 6 (ATF6), and inositol 257 requirement 1 (IRE1), are well-characterized ER membrane-located proteins which 258 sense ER stress. In the presence of ER stress, PERK is activated by 259 trans-autophosphorylation, ATF6 activates expression of the ER chaperone 260 immunoglobulin heavy-chain binding protein (BiP), and IRE1 activates splicing of X-box 261 binding protein 1 (Xbp1) mRNA via the PERK, ATF6, and IRE1 pathways, respectively 262 (Ariyasu et al, 2017; Yoshida, 2007) . PERK phosphorylation can be detected by 263 immunoblotting, as phosphorylated PERK is associated with a mobility shift during 264 SDS-PAGE (Harding et al, 1999) . Immunoblotting revealed that the PERK was 265 phosphorylated in 2 and 4-week-old Gh wtGH1/Δ3GH1 pituitary glands ( Fig 4A) . Further, 266 qRT-PCR demonstrated a significant increase in BiP mRNA abundance in 4-week-old 267 Gh wtGH1/Δ3GH1 pituitary ( Fig 4B) . Xbp1 mRNA splicing was evaluated by competitive 268 RT-PCR, using primers flanking the 26 bp sequence spliced out by IRE1α (Yoshida et al, 269 2001) . Xbp1 mRNA splicing was significantly increased at 1, 2, and 4 weeks of age in 270 Gh wtGH1/Δ3GH1 pituitaries ( Fig 4C and D) . 271
These data suggest that Δ3 GH can activate the three major ER stress pathways 272 in vivo; however, activation of these ER stress pathways is not sufficiently strong to 273 cause somatotroph apoptosis, since no apoptotic cells were detected by TUNEL assay, 274 as described above ( Fig 3B) , and no caspase-3 activation was detected in Gh wtGH1/Δ3GH1 275 pituitary glands by immunoblotting ( Fig 4A) . In other established ER stress-related 276 9 endocrine diseases, apoptosis is required to cause organ dysfunction (Ariyasu et al, 277 2017; Fonseca et al, 2010; Hayashi et al, 2009; Oyadomari et al, 2002; Yoshida, 2007) . 278
These data suggest that Δ3 GH-mediated ER stress is not likely to be causally related 279 to the growth retardation in Gh wtGH1/Δ3GH1 mice. 280
281
Decreased Ghrhr gene promoter activity contributes to decreased wtGH1 gene 282 expression in Gh wtGH1/Δ3GH1 mice 283
Our data (described above) indicate that Δ3 GH itself can decrease wtGH1 mRNA 284 levels, without interacting with wild-type GH protein, ER stress, or apoptosis. revealed that both wtGH1 and Δ3GH1 mRNA were equally decreased in Gh wtGH1/Δ3GH1 286 pituitary ( Fig 2D) , leading us to evaluate the expression levels of genes contributing to 287 upstream regulation of GH1 gene transcription. 288
As wtGH1 mRNA was primarily decreased in Gh wtGH1/Δ3GH1 somatotroph, we would 289 expect the Ghrhr gene to be overexpressed, because of negative feedback 290 mechanisms reflecting the GH deficiency in this tissue. Consistent with this hypothesis, 291 4-week-old Gh -/mice had significantly increased abundance of Ghrhr mRNA compared 292
with Gh wtGH1/wtGH1 mice, because of a negative feedback mechanism, reflecting their 293 complete GH deficiency ( Fig 5A lane 1 and 3, and B ). However, Gh wtGH1/Δ3GH1 mice 294 demonstrated significantly decreased Ghrhr mRNA compared with Gh wtGH1/wtGH1 mice, 295 despite their marked GH deficiency ( Fig 5A lane 1 and 2, and B ). These data suggest 296 that the decrease in wtGH1 mRNA in Gh wtGH1/Δ3GH1 pituitary is mediated, at least in part, 297 by that of Ghrhr mRNA. In agreement with this hypothesis, Gh Δ3GH1/mice demonstrated 298 significantly decreased abundance of Ghrhr mRNA, compared with Gh -/mice, despite 299 the fact that both strains lack the ability to secrete wild-type GH ( Fig 5A lane 3 and 4,  300 and B). Note that Gh Δ3GH1/mice demonstrate exactly the same degree of growth 301 retardation as Gh -/mice, because Δ3 GH is not secreted (Fig 5C and EV2C) . Further, 302 the decrease in both the abundance of wtGH1 mRNA in each somatotroph and the 303 number of somatotrophs in Gh wtGH1/Δ3GH1 pituitaries ( Fig 2G) , can be explained by this 304 decrease in Ghrhr mRNA, because GHRH signaling is essential for GH1 gene 305 transcription and somatotroph proliferation (Lin et al, 1993) . Taken together, Δ3 GH 306 contributes to decreased Ghrhr mRNA levels, without the assistance of wild-type GH, 307 leading to the impaired GHRH signaling and reduced wtGH1 transcription in 308
To evaluate the mechanisms underlying decreases in Ghrhr mRNA, a mouse 310 model with the LacZ gene knocked in to the Ghrhr gene locus (Ghrhr +/LacZ ) was 311 established using the CRISPR/Cas9 gene editing system ( Fig EV3A and B) . E19.5 and 312 10 4-week-old Ghrhr +/LacZ ;Gh wtGH1/Δ3GH1 pituitary showed significantly decreased X-gal 313 staining compared with Ghrhr +/LacZ ;Gh wtGH1/wtGH1 pituitary, indicating that the decreased 314
Ghrhr mRNA levels are caused by a reduction in Ghrhr promoter activity ( Fig 5D) . 315
316
Nuclear expressions of CREB3L2 is decreased in Gh wtGH1/Δ3GH1 pituitary glands 317
The decreased Ghrhr promoter activity detected in Gh wtGH1/Δ3GH1 mice suggests 318 that the expression of nuclear transcription factors crucial for the Ghrhr expression is 319 disturbed by ER-localized Δ3 GH ( Fig 5D) . Furthermore, the abnormal cellular 320 organelles and mildly activated ER stress pathway caused by Δ3 GH, indicate that Δ3 321 GH causes a deterioration in ER function by inducing ER stress ( Fig 3C-E, Fig 4A-D) . 322
Immunoblotting revealed that abundance of the nuclear POU1F1 protein, a well-known 323 transcription factor involved in regulation of Ghrhr and Gh promoter activities, was 324 comparable in 4-week-old Gh wtGH1/wtGH1 and Gh wtGH1/Δ3GH1 pituitaries ( Fig EV3C) , 325
suggesting that other, unknown, pituitary transcription factors were involved in the 326 decreased Ghrhr promoter activity in Gh wtGH1/Δ3GH1 mice. These data led us to focus on 327 the Creb3 family of bZip transcription factors, a recently described family of ER stress 328 transducers, all of which are ER-bound factors that undergo proteolysis in the Golgi 329 apparatus, leading to production of active N-terminal fragments, which translocate to 330 the nucleus and activate transcription of target genes (Kondo et al, 2011) . Creb3l1 KO mice display mild growth failure, which is not rescued by osteoblast-specific 340
Creb3l1 overexpression, but can be ameliorated by exogenous GH treatment, 341 suggesting that they have impaired GH secretion (Murakami et al, 2011) . Furthermore, 342 TEM images of Creb3l1-deficient osteoblasts and Creb3l2-deficient chondrocytes 343 showed abnormal enlarged ER (Murakami et al, 2009; Saito et al, 2009 ), similar to 344 those detected in Gh wtGH1/Δ3GH1 somatotroph. These similarities between Gh wtGH1/Δ3GH1 345 and Creb3 family KO mice led us to hypothesize that one or more Creb3 family 346 members are crucial for Ghrhr gene expression, and that the growth failure of 347 Gh wtGH1/Δ3GH1 mice is mediated by decreased levels of nuclear active N-terminal Creb3 348 11 protein fragments. 349
RT-PCR analysis of pituitary glands from 4-week-old C57BL/6 mice revealed that 350 the Creb3l1 and Creb3l2 genes were strongly expressed in this tissue ( Fig 6A) . Next, 351 we evaluated expression of these two genes in 4-week-old Gh wtGH1/wtGH1 and 352
Gh wtGH1/Δ3GH1 pituitaries by qRT-PCR and immunoblotting. In Gh wtGH1/Δ3GH1 pituitary, the 353 abundance of Creb3l1 mRNA was increased, while that of the N-terminal CREB3L1 354 protein was comparable with levels in the Gh wtGH1/wtGH1 pituitary (Fig 6B and C) . 355 Furthermore, in Gh wtGH1/Δ3GH1 pituitary, Creb3l2 mRNA levels were comparable, while 356 those of N-terminal CREB3L2 protein were reduced, compared with Gh wtGH1/wtGH1 357 pituitary ( Fig 6B and C) . Both CREB3L1 and CREB3L2 were demonstrated to be 358 expressed in somatotroph by immunofluorescence ( Fig EV3D) . These data indicate that 359 expression levels of N-terminal CREB3L1 and CREB3L2 proteins are disturbed in 360
Gh wtGH1/Δ3GH1 mice. 361
Since involvement of N-terminal CREB3L1 and CREB3L2 in GH production has 362 not been described previously, we evaluated the impact of N-terminal CREB3L1 and 363 CREB3L2 on Ghrhr and the Gh promoter activities in vitro. Luciferase assays revealed 364 that N-terminal CREB3L2 strongly stimulated transcription from both the Ghrhr and Gh 365 promoters, in combination with POU1F1 ( Fig 6D) . Decreased nuclear CREB3L2 levels 366
were also demonstrated at embryonic stages in Gh wtGH1/Δ3GH1 pituitary glands by 367 immunoblotting. Ratios of N-terminal CREB3L2 to full-length CREB3L2 decreased in 368
Gh wtGH1/Δ3GH1 pituitary glands at embryonic day E19.5 ( Fig 6E and F) , indicating that 369 translocation of CREB3L2 to the nucleus was disturbed by ER-localized Δ3 GH. Sec23a 370 mRNA, an established target gene of nuclear CREB3L2, was also decreased in 371 Gh wtGH1/Δ3GH1 pituitary at E19.5 ( Fig 6G) . These data suggest that CREB3L2 stimulates 372
Ghrhr and the Gh gene expression levels, and that impaired GH production in 373 Gh wtGH1/Δ3GH1 somatotroph is mediated by a decrease in nuclear CREB3L2 levels. 374 375 Discussion 376 377 The gene exchange system used in this study is a useful method for establishing 378 mouse models of human diseases, because once researchers obtain a gene of interest 379 flanked by mutated lox sites, they can easily exchange the endogenous genes with 380 various human genes, via Cre-mediated integration. Using this system, we established 381 a mouse model that expresses the wtGH1 and Δ3GH1 genes, instead of endogenous 382 mouse Gh. Gh wtGH1/Δ3GH1 mice have two advantages: 1) endogenous mouse GH is not 383 produced and 2) one copy each of human wild-type GH and Δ3 GH are expressed 384 under the control of the Gh promoter. Thus, Gh wtGH1/Δ3GH1 mice are a genetically ideal 385 model that mimics the growth patterns of human patients with IGHD2. 386
For functional analysis of secretory molecules regulated by feedback mechanisms 387 involving in multiple tissues, such as GH, it is important to establish an applicable model 388 that replicates the human disease as precisely as possible. Since patients with IGHD2 389 were first described in 1994, many researchers have focused on interference of 390 wild-type GH protein trafficking by Δ3 GH, and several in vitro studies have been 391 conducted to investigate the dominant negative effect of Δ3 GH (Ariyasu et al, 2013; 392 Graves et al, 2001; Hayashi et al, 1999; Iliev et al, 2005; Kannenberg et al, 2007; Lee et 393 al, 2000; McGuinness et al, 2003; Salemi et al, 2006; Salemi et al, 2007) ; however, in 394 these studies, wild-type and Δ3 GH expression were driven by homeostatic promoters, 395 such as the CMV promoter, and were thus independent of the feedback mechanisms 396 that regulate GH expression in vivo. Furthermore, pituitary-derived cell lines, such as 397 GC, GH3, GH4C1, and used EV1E and F). Further, a previous study using cultured lymphocytes from patients with 407 IGHD2 revealed that ratios of mutant to wild-type GH1 transcripts were correlated with 408 the severity of GH deficiency (Hamid et al, 2009). 409 In this study, we reveal two important findings: 1) Impaired GH secretion in 410
Gh wtGH1/Δ3GH1 mice is caused by decreased activity of the Ghrhr and Gh promoters; 2) 411 these decreases in promoter activity are mediated by reduced levels of nuclear 412 CREB3L2. A schematic representation of the molecular mechanisms underlying GH 413 deficiency in IGHD2 is presented in Fig 7. Our data, including the abnormal TEM 414 images and activated ER stress responses in Gh wtGH1/Δ3GH1 pituitary, indicate that 415 ER-localized Δ3 GH diminishes ER function by invoking ER stress. Δ3 GH-mediated ER 416 stress leads to a decrease in COPII vesicles, which are essential for ER-Golgi transport, 417 because Δ3 GH disturbs ER-Golgi transport (Graves et al, 2001) and COPII vesicles 418 can be reduced under ER stress conditions (Shaheen, 2018) . Full-length CREB3L2 is 419 transported to the Golgi, where it is cleaved to produce the active N-terminal 420 13 transcription factor (Kondo et al, 2011); thus a decrease in ER-Golgi transport is 421 expected to reduce nuclear N-terminal CREB3L2 levels, leading to downregulation of 422 both Ghrhr and GH1 gene transcription. The decreased levels of N-terminal CREB3L2 423 disturb ER-Golgi transport in vicious cycle, since Sec23a, an established target gene of 424 N-terminal CREB3L2, encodes SEC23, which is a COPII vesicle coat protein (Saito et al, 425 2009 ). Decreased ER-Golgi transport will also influence intracellular protein trafficking 426 of wild-type GH and GHRHR, exacerbating the impaired secretion of wild-type GH. 427 Furthermore, decreased GHRH signaling contributes to GH deficiency through inhibition 428 of somatotroph proliferation. In contrast, decreased Δ3GH1 gene transcription limits the 429 accumulation of Δ3 GH in the ER, which likely protects the somatotroph from massive 430 ER stress and apoptosis (Fig 7) . To our knowledge, this is the first in vivo study that has 431 come close to determining the molecular mechanisms underlying GH deficiency in 432
IGHD2. 433
The involvement of other transcriptions factors, such as CREB3L1 and/or 434 unknown molecules, in the reduction of Ghrhr and Gh promoter activities is possible. 435
Creb3 members can interact with other bZip transcription factors as heterodimers, to 436 coordinately stimulate transcription of target genes (Saito et al, 2012; Vecchi et al, 2009; 437 Zhang et al, 2006) . Hence, identifying the partner molecule of CREB3L2 will be 438 necessary for complete elucidation of the molecular mechanisms involved in IGHD2 GH 439 deficiency. 440
We presume that CREB3L2 has an important role in the differentiation and 441 proliferation of somatotroph at the late embryonic stage, by stimulating GHRHR and 442 GH1 gene transcription and increasing their secretion, similar to its role in chondrocytes. 443
Postnatal growth has not been described in Creb3l2-deficient mice because systemic 444
Creb3l2 KO mice are lethal soon after birth (Saito et al, 2009 ). Thus, establishment of 445 somatotroph-specific Creb3l2 conditional KO mice, and/or Gh wtGH1/Δ3GH1 mice 446 overexpressing Creb3l2 specifically in the somatotroph, would be warranted in the 447 future. 448
Interestingly, exon 3 of the GH1 gene has weak splice sites, and a small amount 449 of Δ3 GH is produced in the pituitary glands, even in healthy individuals (Lecomte et al, 450 1987; Ryther et al, 2004) . Δ3 GH may have a physiological role in preventing 451 hyperproliferation of somatotroph and overexpression of the GH1 gene, through the 452 CREB3L2-mediated inhibition of GHRHR and GH1 transcription. 453
This study has some limitations: 1) it remains unclear whether decreased activity 454 of the Ghrhr and Gh promoters contributes to the GH deficiency in human IGHD2 455 patients, because patient pituitary samples are not available. Establishment of 456 14 somatotrophs using induced pluripotent stem (iPS) cells derived from IGHD2 patients 457 will help address this issue. 2) The observed decreases in transcriptional activity could 458 be attributed to the influence of the gene exchange process (described in Fig EV1F) on 459 amount of Δ3 GH protein produced, and the cellular characteristics of somatotrophs. 460
In this study, CREB3L1 and CREB3L2 were demonstrated to be involved in GH 461 production in somatotrophs. These findings suggest that patients with GH deficiency 462 may have mutations in the Creb3l1 or Creb3l2 genes, or their binding sites in the Ghrhr 463 and Gh promoters. 464
In conclusion, IGHD2 model mice, created using our gene exchange system, 465 reveal a novel molecular mechanism underlying GH deficiency, where ER-localized Δ3 466 GH leads to decreased levels of nuclear CREB3L2, and a consequent reduction in the 467 activities of the Ghrhr and Gh promoters. 468 469
Materials and Methods

471
Isolation of the wtGH1 and Δ3GH1 genes 472
The wtGH1 genomic sequence was amplified from healthy human control 473 lymphocyte DNA using standard PCR methods with a sense primer (GH1-gf1) in the 474 5-untranslated region (UTR) and an antisense primer (GH1-gr1) including the 475 termination codon. The Δ3GH1 genomic sequence, which contains a c.291+1 g>a 476 mutation, was created by mutagenesis, using sense (GH1IVS3-F) and antisense 477 (GH1IVS3dsmut-R) primers containing the single nucleotide substitution. None of the 478 nucleotide polymorphisms, reported to be significantly associated with adult height 479 (Hasegawa et al, 2000) were included in the sequences. All primers used in this study 480 are listed in Supplementary Table 1 . 481
482
Plasmids 483
For KO of the Gh gene, the 5 (7 kb) and 3 (3 kb) arms were isolated by standard 484 PCR methods, using a mouse bacterial artificial chromosome containing the Gh gene 485 locus as a template, with sense (Gh-5arm-F and Gh-3arm-F) and antisense (Gh-5arm-R 486 and Gh-3arm-R) primers. These 5 and 3 arms were inserted into the gene KO vector 487 ( Fig EV1A) . 488
The wtGH1, Δ3GH1, Δ3GH1-myc, or Gh gene genomic sequences were inserted 489 to the cassette exchange vector using appropriate restriction enzymes. 490
To establish the mouse model with LacZ knocked-in at the Ghrhr gene locus, 5 491 (500 bp) and 3 (450 bp) arms were isolated by standard PCR methods, using sense 492 15 (Ghrhr-5arm-f5 and Ghrhr-3arm-f6) and antisense (Ghrhr-5arm-r5 and Ghrhr-3arm-r6) 493 primers, and inserted into a plasmid containing the LacZ gene ( Fig EV3A) . 494
For CRISPR/Cas9 system plasmids, two pairs of oligonucleotides 495 (Ghrhr-CRI-f1/r1, Ghrhr-CRI-f2/r2, Ghrhr-CRI-f4/r4, Ghrhr-CRI-f5/r5) were annealed 496 and inserted into the pX335-U6-Chimeric_BB-CBh-hSpCas9n(D10A) plasmid (Addgene 497 #42335) (pX335-Ghrhr-1, 2, 4, 5, and pX335-Rosa-3, 4). 498
For POU1F1, CREB3L1, and CREB3L2 expression plasmids their open reading 499 frames (ORF) were isolated by standard PCR from C57BL/6 pituitary gland template 500 cDNA using sense (Pou1f1-vf1, Creb3l1-vf1, and Creb3l2-vf1) and antisense 501 (Pou1f1-vr1, Creb3l1-vr1, and Creb3l2-vr1) primers, and inserted into the pcDNA4 502 vector (Invitrogen). 503
For luciferase assay plasmids, the promoter regions of the Ghrhr (500 bp) and Gh 504 (400 bp) genes were isolated from C57BL/6 mouse genomic DNA by standard PCR and 505 inserted into the pGL4.10 vector (Promega). 506
For RNA probes to detect GH1 and Ghrhr mRNAs by in situ hybridization, exon 3 507 of the GH1 gene (120 bp) and the Ghrhr ORF (1272 bp) were amplified by PCR using 508 sense (GH1ex3-f1 and Ghrhr-vf1) and antisense (GH1ex3-r1 and Ghrhr-vr1) primers, 509 with C57BL/6 pituitary gland cDNA as a template, and inserted into the pSP73 vector 510 (Promega). 511 512 Embryonic stem cell culture and electroporation 513 KTPU8 feeder free ES cells, derived from F1 mice obtained by crossing C57BL/6 514 and CBA strains, were seeded into dishes pretreated with 0.15% gelatin solution, and 515 cultured in Glasgow minimum essential medium, 14% knockout serum replacement, 516 and 100 IU/ml leukemia inhibitory factor. To establish Gh +/-ES cells, KTPU8 cells 517 cultured in a 10 cm culture dish were electroporated (0.8 kV/3 µF) with 20 µg linearized 518 KO vector containing a neomycin resistance (neoR) gene flanked by the 5 and 3 arms, 519 and seeded into four 10 cm culture dishes. Culture medium containing 180 µg/mL 520 neomycin was exchanged daily. Nine days after electroporation, the surviving clones 521 were picked and DNA from each clone was evaluated by Southern blotting (Fig EV1A  522 and B). 523
To exchange the neoR gene for human GH1 genes, the Gh +/-ES clones cultured 524 in one 10 cm culture dish were electroporated (0.4 kV/125 µF) with 20 µg exchangeable 525 vector and 10 µg Cre expression vector. Culture medium containing 0.8 µg/mL 526 puromycin was exchanged daily, and the DNA samples of surviving clones were 527 evaluated by Southern blotting (Fig EV1A and B) . 528
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To establish a mouse model in which the LacZ gene was knocked-in at the Ghrhr 529 gene locus, ES cells derived from C57BL/6 mice were electroporated (0.4 kV/125 µF) 530 with 25 µg plasmid containing the LacZ gene flanked by Ghrhr homology arms, 531 pX335-Ghrhr-1 and pX335-Ghrhr-2 (15 µg each) ( Fig EV3A) . For this process, we took 532 advantage of D10A mutant Cas9, to avoid making double-strand breaks (Cong et al, 533 2013; Jinek et al, 2012) . 534 535
Southern Blotting 536
Southern blotting was conducted using DIG, according to the manufacturer's 537 protocol. For Gh gene knockout, homologous recombination of the neoR gene was 538 confirmed by Southern blotting using probes for sequences flanking the 5 and 3 arms, 539 and the neoR gene ( Fig EV1A and B) . Substitution of the GH1 gene for neoR was also 540 evaluated by Southern blotting, using probes for the puromycin resistance gene (PuroR) 541 ( Fig EV1B) . To evaluate knock-in of the LacZ gene at the Ghrhr gene locus, Southern 542 blotting was performed, using probes for sequences flanking the 5 and 3 arms ( Fig  543   EV3A and B) . 544
545
RT-PCR and quantitative RT-PCR (qRT-PCR) 546
Total RNA was extracted from mouse pituitaries using an RNeasy mini kit 547 (Qiagen) and 250 ng converted to cDNA using Revertra Ace (TOYOBO, Osaka, Japan, 548 FSQ-101). cDNA aliquots were used for RT-PCR and qRT-PCR. 549 For immunoblotting assays, the following primary antibodies were used: 1) 563 anti-GH rabbit polyclonal antibody (Dako, A0570) (dilution 1:3000); 2) anti-PERK rabbit 564 monoclonal antibody C33E10 (Cell Signaling Technology, 3192) (dilution 1:1000); 3) 565 anti-caspase-3 rabbit monoclonal antibody 8G10 (Cell Signaling Technology, 9665) 566 (dilution 1:1000); 4) anti-GRP78 rabbit monoclonal antibody EPR4041(2) (Abcam, 567 ab108615) (dilution 1:500); 5) anti-GAPDH mouse monoclonal antibody 6C5 (Santa 568 Cruz, sc-32233) (dilution 1:5000); 6) anti-LAMIN A/C rabbit polyclonal antibody (Cell 569 Signaling Technology, 2032) (dilution 1:1000); 7) anti-POU1F1 mouse monoclonal 570 antibody 2C11 (Abcam, ab10623) (dilution 1:1000); 8) anti-CREB3L1 mouse 571 monoclonal antibody 44c7 (Merck Millipore, MABE1017) (dilution 1:1000); 9) 572 anti-CREB3L2 rabbit polyclonal antibody (kindly provided by Prof. Imaizumi, Hiroshima 573 University, Japan) (dilution 1:1000). Anti-rabbit immunoglobulin (IgG) (Dako, P0399) 574 and anti-mouse immunoglobulin (Abcam, ab205719) (dilution 1:5000) secondary 575 antibodies were used. 576
For immunohistochemistry, the following primary antibodies were used at a 1:100 577 dilution: 1) anti-GH rabbit polyclonal antibody (Dako, A0570); 2) anti-GH mouse 578 monoclonal antibody (Abcam, ab15317); 3) anti-CREB3L1 rabbit polyclonal antibody 579 
3-D structural analyses of GH proteins 593
The 3-D structure of wild-type GH was obtained from the Protein Data Bank (PDB 594 ID: 1AXI) and that of Δ3 GH was analyzed using the homology model function of MOE 595 software (Chemical Computing Group Inc.), as described previously (Nakamura et al, 596 2017; Ogasawara et al, 2016) . Hydrogen atoms were then added to each protein, using 597 the protonate 3D function of MOE under ER pH conditions (Kim et al, 1998) . These 598 structures were then subjected to molecular mechanics (MM) calculations using MOE, 599 with the AMBER99 force field, until the root mean square gradient was 0.01 kcal/mol/Å. 600
After heating for 250 ps to attain 310 K as the starting temperature, a 5000 ps 601 production run of the molecular dynamic (MD) simulation was performed at 310 K, with 602 NPT ensemble using NAMD software (Phillips et al, 2005) . 603 604
Docking simulation analysis of dimeric GH molecules 605
Docking simulations were performed using ZDOCK (Chen et al, 2003) with 606 residues within 10 Å of cysteine residues (numbers 79, 191, 208, and 215) ICR and C57BL/6 mice were purchased from CLEA Japan, Inc. Egg zona 615 pellucida from E2.5 ICR mouse embryos were removed and aggregated with KTPU8 616 ES clones. The resulting blastocysts were transferred to the uteruses of ICR female 617 mice mated with vasoligated male mice. F0 mice, with 100% chimerism, were crossed 618 with C57BL/6 mice, to obtain N1 offspring. Gh wtGH1/wtGH1 and Gh wtGH1/Δ3GH1 mice were 619 backcrossed to C57BL/6 mice for at least ten generations. 620
621
Genotyping 622
To determine mouse genotypes, standard PCR reactions were performed using 623 template DNA samples extracted from toe clips from 7-day-old mice (Fig EV1A and D) . 624 A reverse primer with the 3 end converted to thymine from cytosine at the first base of 625 the intron 3 in the GH1 gene (primer No. 4, completely matching the Δ3GH1 allele) was 626 used. PCR reactions to detect both wtGH1 and Δ3GH1 alleles used an annealing 627 temperature of 60℃, with those to detect only the Δ3GH1 allele using an annealing 628 temperature of 66℃ ( Fig EV1D) . The sequences of all primers used in this study are 629 listed in Table 1 . 630 631
Measurement of mouse body weight and length 632
Mouse body weights were measured every week from 1 to 16 weeks of age. Body 633 lengths (distances from nose to anus) were measured under anesthesia, induced using 634 isoflurane, every 4 weeks from 4 to 16 weeks of age, using a ruler. 635 636
Measurement of mouse serum IGF-1 concentration 637
Blood samples were obtained from mouse orbital veins at 4 weeks of age, using a 638 heparinized tube. Samples were centrifuged at 3000 rpm for 5 min, to collect serum 639 samples collected. IGF-1 concentrations were evaluated using a Mouse/Rat IGF-1 640 ELISA Kit (ALPCO, 22-IG1MS-E01). 641 642 Hematoxylin and eosin (HE) staining, TUNEL assay, and Immunohistochemistry 643
Pituitary glands were fixed in 4% paraformaldehyde (PFA) for 24 h at 15-25 644 ℃, dehydrated through increasing concentrations of ethanol, equilibrated with xylene, 645 embedded in paraffin wax, and sectioned at 4 µm. Pituitary sections were stained with 646 hematoxylin and eosin and examined by light microscopy. TUNEL assays were 647 performed using an ApopTag Peroxidase In Situ Apoptosis Detection Kit (Millipore, 648 S7100). Thymus sections were used as positive controls. For immunostaining of GH, 649 pituitary sections were deparaffinized, rehydrated, and treated with 20 µg/ml proteinase 650 K as an antigen retrieval step. Antibodies are described in the 'antibodies' section above. 651
Staining was performed using diaminobenzidine (DAB) and hematoxylin. 652 653
Immunofluorescence assay 654
Pituitary glands were fixed in 4% PFA for 2 h at room temperature, dehydrated 655 through increasing concentrations of sucrose, embedded in Optimal Cutting 656 Temperature Compound, and sectioned at 6 µm. Frozen pituitary sections were 657 subjected to immunofluorescence analysis. 658 659
In situ hybridization 660
Pituitary glands were fixed in 4% PFA for 48 h at room temperature. 661
Deparaffinization, cell conditioning, prehybridization, and stringency washing were 662 automated using a staining workstation (Ventana Discovery XT). RNA probes were 663 synthesized by in vitro transcription, and labelled with digoxigenin (DIG), using a DIG 664 RNA labeling kit (Roche, 11175025910). Probes for wtGH1 and Ghrhr mRNAs were 665 manually hybridized at 0.5 ng/ml, 65℃ for 6 h, and 10 ng/ml, 68℃ for 6 h, respectively. 666 667
Transmission electron microscopy 668
Pituitary glands from four-week-old mice were used for TEM observation, as 669 described previously (Shibata et al, 2015) . Briefly, tissues were dissected out and fixed 670 in 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 24 h at 4°C. After 2 h 671 post-fixation with 1% OsO 4 and dehydration through ethanol, then acetone with n-butyl 672 20 glycidyl ether (QY1) including a graded concentration of Epon with QY-1, they were 673 embedded into 100% Epon. Following 72 h of polymerization in pure Epon, 70 nm 674 ultrathin coronal pituitary gland sections were prepared on copper grids and stained with 675 uranyl acetate and lead citrate for 10 min. Sections were observed under a TEM (JEOL 676 JEM-1400 plus). 677 678
X-gal staining of pituitary glands 679
Pituitary glands were removed from four-week-old mice and fixed in 4% PFA for 1 680 h on ice. Then, samples were permeabilized using rinse buffer (phosphate buffered 681 saline (PBS) containing 2 mM MgCl 2 , 0.01% sodium deoxycholate, and 0.02% Nonidet 682 P-40) for 2 h on ice, washed three times for 30 min in PBS, and stained in rinse buffer 683 containing 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and 1 mg/ml 684 5-Bromo-4-Chloro-3-Indolyl-β-D-Galactoside (X-gal) overnight at 37℃. For E19.5 685 embryo samples, heads were removed and fixed in 4% PFA for 30 min on ice. Then, 686 pituitary glands were exposed by removing the skull bone and brain before 687 permeabilization using rinse buffer. 688 689
Dissociation of pituitary cells 690
Anterior pituitary cells were dissociated, according to published methods, using 691 0.5 % trypsin-EDTA (Oomizu et al, 1998) . 692 693
Soluble/insoluble fraction assay, cytoplasmic/nuclear fraction assay 694
For soluble/insoluble fraction assays, anterior pituitary cells were dissociated as 695 described above, and 0.5 x 10 6 cells seeded in DMEM with 10% FBS in a 24-well plate 696 with 10 µM MG132 (Peptide Institute, Osaka, Japan), or DMSO, for 4 h. Detailed 697 procedures have been described elsewhere (Ariyasu et al, 2013 wild-type GH wild-type GH CREB3L2 CREB3L1
